Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
TEST:
Cxbladder
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
Pacific Edge
Type:
Laboratory Developed Test
Details
Evidence
News
Search handles
Search handles
Filter by
Latest
8ms
From science to clinical utility: @Cxbladder Detect - #BladderCancer detection for patients who present with hematuria. Tamer Aboushwareb, MD, PhD @PacificEdgeLtd, Neal Shore, MD, FACS @AtlanticUrology & @JoshMeeks @NM_Urology join to discuss on UroToday > https://t.co/ntpVmbLok6 (@urotoday)
8 months ago
Clinical
|
Cxbladder
9ms
@Cxbladder Monitor testing to reduce cystoscopy frequency in patients with #BladderCancer. #BeyondTheAbstract with Kevin Li, @CChuMD, Milan Patel, @Uro_Max, @wandering_gu, and @SimaPorten. #ReadNow on UroToday > https://t.co/3B6SPksAcw @UrolOncol @PacificEdgeLtd (@urotoday)
9 months ago
Clinical
|
Cxbladder
9ms
From science to clinical utility: @Cxbladder Detect - #BladderCancer detection for patients who present with hematuria. Tamer Aboushwareb, MD, PhD @PacificEdgeLtd, Neal Shore, MD, FACS @AtlanticUrology & @JoshMeeks @NM_Urology join to discuss on UroToday > https://t.co/ntpVmbLok6 (@urotoday)
9 months ago
Clinical
|
Cxbladder
9ms
From science to clinical utility: @Cxbladder Monitor - #BladderCancer surveillance for patients with urothelial carcinoma. Tamer Aboushwareb, MD, PhD @PacificEdgeLtd, Neal Shore, MD, FACS @AtlanticUrology & @JoshMeeks @NM_Urology > https://t.co/cJqV3Ay8oS (@urotoday)
9 months ago
Clinical
|
Cxbladder
10ms
@Cxbladder Monitor testing to reduce cystoscopy frequency in patients with #BladderCancer. #BeyondTheAbstract with Kevin Li, @CChuMD, Milan Patel, @Uro_Max, @wandering_gu, and @SimaPorten. #ReadNow on UroToday > https://t.co/3B6SPks2mY @UrolOncol @PacificEdgeLtd (@urotoday)
10 months ago
Clinical
|
Cxbladder
10ms
From science to clinical utility: @Cxbladder Detect - #BladderCancer detection for patients who present with hematuria. Tamer Aboushwareb, MD, PhD @PacificEdgeLtd, Neal Shore, MD, FACS @AtlanticUrology & @JoshMeeks @NM_Urology join to discuss on UroToday > https://t.co/ntpVmbLok6 (@urotoday)
10 months ago
Clinical
|
Cxbladder
10ms
From science to clinical utility: @Cxbladder Monitor - #BladderCancer surveillance for patients with urothelial carcinoma. Tamer Aboushwareb, MD, PhD @PacificEdgeLtd, Neal Shore, MD, FACS @AtlanticUrology & @JoshMeeks @NM_Urology > https://t.co/cJqV3Ay8oS (@urotoday)
10 months ago
Clinical
|
Cxbladder
11ms
@Cxbladder Monitor testing to reduce cystoscopy frequency in patients with #BladderCancer. #BeyondTheAbstract with Kevin Li, @CChuMD, Milan Patel, @Uro_Max, @wandering_gu, and @SimaPorten. #ReadNow on UroToday > https://t.co/3B6SPks2mY @UrolOncol @PacificEdgeLtd (@urotoday)
11 months ago
Clinical
|
Cxbladder
11ms
From science to clinical utility: @Cxbladder Detect - #BladderCancer detection for patients who present with hematuria. Tamer Aboushwareb, MD, PhD @PacificEdgeLtd, Neal Shore, MD, FACS @AtlanticUrology & @JoshMeeks @NM_Urology join to discuss on UroToday > https://t.co/ntpVmbLok6 (@urotoday)
11 months ago
Clinical
|
Cxbladder
12ms
From science to clinical utility: @Cxbladder Monitor - #BladderCancer surveillance for patients with urothelial carcinoma. Tamer Aboushwareb, MD, PhD @PacificEdgeLtd, Neal Shore, MD, FACS @AtlanticUrology & @JoshMeeks @NM_Urology > https://t.co/cJqV3Ay8oS (@urotoday)
12 months ago
Clinical
|
Cxbladder
12ms
From science to clinical utility: @Cxbladder Detect - #BladderCancer detection for patients who present with hematuria. Tamer Aboushwareb, MD, PhD @PacificEdgeLtd, Neal Shore, MD, FACS @AtlanticUrology & @JoshMeeks @NM_Urology join to discuss on UroToday > https://t.co/ntpVmbLW9E (@urotoday)
12 months ago
Clinical
|
Cxbladder
12ms
If you manage patients with non muscle invasive bladder cancer, Cxbladder Monitor can help reduce the burden of surveillance cystoscopy. @SimaPorten and @DrJohnSfakianos join me to discuss their data and experience. https://t.co/tB63ExaqfT (@dshoskes)
12 months ago
Clinical
|
Cxbladder
1year
From science to clinical utility: @Cxbladder Monitor - #BladderCancer surveillance for patients with urothelial carcinoma. Tamer Aboushwareb, MD, PhD @PacificEdgeLtd, Neal Shore, MD, FACS @AtlanticUrology & @JoshMeeks @NM_Urology > https://t.co/cJqV3Ay8oS ()
1 year ago
Clinical
|
Cxbladder
1year
“Remote” monitoring in urologic cancer: the case for home-based testing in #BladderCancer. Presentation by @SimaPorten @UCSFCancer. #SUO22 written coverage by @rksayyid @UofT > https://t.co/gkMk7Kayg1 @UroOnc @SUO_YUO @Cxbladder @PacificEdgeLtd ()
1 year ago
Cxbladder
1year
"Kevin Li, Sima Porten et al on "Cxbladder Monitor Testing to Reduce Cystoscopy Frequency in Patients with Bladder Cancer" in @UrolOncol" @SimaPorten, @CChuMD, @Uro_Max Read more here: https://t.co/vlN96sF9V8 ()
1 year ago
Clinical
|
Cxbladder
1year
From science to clinical utility: @Cxbladder Detect - #BladderCancer detection for patients who present with hematuria. Tamer Aboushwareb, MD, PhD @PacificEdgeLtd, Neal Shore, MD, FACS @AtlanticUrology & @JoshMeeks @NM_Urology join to discuss on UroToday > https://t.co/ntpVmbLW9E ()
1 year ago
Clinical
|
Cxbladder
1year
Proud to share our findings on use of @Cxbladder Monitor during the #COVID19 pandemic to allow bladder cancer patients to skip in-person surveillance cystoscopy w/ negative test. Huge thanks to mentors @SimaPorten @CChuMD et al. for the support and guidance! ()
1 year ago
Clinical
|
Cxbladder
1year
The real-life impact of @Cxbladder tests on diagnosis and surveillance of #BladderCancer. Presentation by @siadaneshmand @KeckMedUSC. #SUO22 written coverage by @rksayyid @UofT on UroToday > https://t.co/cdcwY5kGP0 @UroOnc @SUO_YUO @PacificEdgeLtd ()
1 year ago
Clinical
|
Cxbladder
1year
💥#MayoMGR today with @MarkTysonMD : "Hematuria – What is on the Horizon?" 💡Only 5% of #microhematuria pts have #bladdercancer➡️NPV of doing nothing is 95%! @MayoUrology @MayoMitch @Dr_Vijay_Shah #Hematuria #Cxbladder #Cystoscopy #UroTwitter #OncTwitter #MedTwitter ()
1 year ago
Clinical
|
Cxbladder
1year
From science to clinical utility: @Cxbladder Monitor - #BladderCancer surveillance for patients with urothelial carcinoma. Tamer Aboushwareb, MD, PhD @PacificEdgeLtd, Neal Shore, MD, FACS @AtlanticUrology & @JoshMeeks @NM_Urology > https://t.co/cJqV3Ay8oS ()
1 year ago
Clinical
|
Cxbladder
1year
“Remote” monitoring in urologic cancer: the case for home-based testing in #BladderCancer. Presentation by @SimaPorten @UCSFCancer. #SUO22 written coverage by @rksayyid @UofT > https://t.co/gkMk7Kayg1 @UroOnc @SUO_YUO @Cxbladder @PacificEdgeLtd ()
1 year ago
Cxbladder
1year
From science to clinical utility: @Cxbladder Detect - #BladderCancer detection for patients who present with hematuria. Tamer Aboushwareb, MD, PhD @PacificEdgeLtd, Neal Shore, MD, FACS @AtlanticUrology & @JoshMeeks @NM_Urology join to discuss on UroToday > https://t.co/ntpVmbLok6 ()
1 year ago
Clinical
|
Cxbladder
1year
The real-life impact of @Cxbladder tests on diagnosis and surveillance of #BladderCancer. Presentation by @siadaneshmand @KeckMedUSC. #SUO22 written coverage by @rksayyid @UofT on UroToday > https://t.co/cdcwY5leEy @UroOnc @SUO_YUO @PacificEdgeLtd ()
1 year ago
Clinical
|
Cxbladder
1year
“Remote” monitoring in urologic cancer: the case for home-based testing in #BladderCancer. Presentation by @SimaPorten @UCSFCancer. #SUO22 written coverage by @rksayyid @UofT > https://t.co/gkMk7Kayg1 @UroOnc @SUO_YUO @Cxbladder @PacificEdgeLtd ()
1 year ago
Cxbladder
1year
From science to clinical utility: @Cxbladder Monitor - #BladderCancer surveillance for patients with urothelial carcinoma. Tamer Aboushwareb, MD, PhD @PacificEdgeLtd, Neal Shore, MD, FACS @AtlanticUrology & @JoshMeeks @NM_Urology > https://t.co/cJqV3AyGeq ()
1 year ago
Clinical
|
Cxbladder
1year
From science to clinical utility: @Cxbladder Detect - #BladderCancer detection for patients who present with hematuria. Tamer Aboushwareb, MD, PhD @PacificEdgeLtd, Neal Shore, MD, FACS @AtlanticUrology & @JoshMeeks @NM_Urology join to discuss on UroToday > https://t.co/ntpVmbLok6 ()
1 year ago
Clinical
|
Cxbladder
1year
The real-life impact of @Cxbladder tests on diagnosis and surveillance of #BladderCancer. Presentation by @siadaneshmand @KeckMedUSC. #SUO22 written coverage by @rksayyid @UofT on UroToday > https://t.co/cdcwY5kGP0 @UroOnc @SUO_YUO @PacificEdgeLtd ()
1 year ago
Clinical
|
Cxbladder
1year
“Remote” monitoring in urologic cancer: the case for home-based testing in #BladderCancer. Presentation by @SimaPorten @UCSFCancer. #SUO22 written coverage by @rksayyid @UofT > https://t.co/gkMk7Kayg1 @UroOnc @SUO_YUO @Cxbladder @PacificEdgeLtd ()
1 year ago
Cxbladder
1year
From science to clinical utility: @Cxbladder Detect - #BladderCancer detection for patients who present with hematuria. Tamer Aboushwareb, MD, PhD @PacificEdgeLtd, Neal Shore, MD, FACS @AtlanticUrology & @JoshMeeks @NM_Urology join to discuss on UroToday > https://t.co/ntpVmbLok6 ()
1 year ago
Clinical
|
Cxbladder
over1year
The real-life impact of @Cxbladder tests on diagnosis and surveillance of #BladderCancer. Presentation by @siadaneshmand @KeckMedUSC. #SUO22 written coverage by @rksayyid @UofT on UroToday > https://t.co/cdcwY5kGP0 @UroOnc @SUO_YUO @PacificEdgeLtd ()
over 1 year ago
Clinical
|
Cxbladder
over1year
The real-life impact of @Cxbladder tests on diagnosis and surveillance of #BladderCancer. Presentation by @siadaneshmand @KeckMedUSC. #SUO22 written coverage by @rksayyid @UofT on UroToday > https://t.co/cdcwY5kGP0 @UroOnc @SUO_YUO @PacificEdgeLtd ()
over 1 year ago
Clinical
|
Cxbladder
over1year
“Remote” monitoring in urologic cancer: the case for home-based testing in #BladderCancer. Presentation by @SimaPorten @UCSFCancer. #SUO22 written coverage by @rksayyid @UofT > https://t.co/gkMk7Kayg1 @UroOnc @SUO_YUO @Cxbladder @PacificEdgeLtd ()
over 1 year ago
Cxbladder
over1year
From science to clinical utility: @Cxbladder Monitor - #BladderCancer surveillance for patients with urothelial carcinoma. Tamer Aboushwareb, MD, PhD @PacificEdgeLtd, Neal Shore, MD, FACS @AtlanticUrology & @JoshMeeks @NM_Urology > https://t.co/cJqV3Ay8oS ()
over 1 year ago
Clinical
|
Cxbladder
over1year
From science to clinical utility: @Cxbladder Detect - #BladderCancer detection for patients who present with hematuria. Tamer Aboushwareb, MD, PhD @PacificEdgeLtd, Neal Shore, MD, FACS @AtlanticUrology & @JoshMeeks @NM_Urology join to discuss on UroToday > https://t.co/ntpVmbLok6 ()
over 1 year ago
Clinical
|
Cxbladder
over1year
From science to clinical utility: @Cxbladder Monitor - #BladderCancer surveillance for patients with urothelial carcinoma. Tamer Aboushwareb, MD, PhD @PacificEdgeLtd, Neal Shore, MD, FACS @AtlanticUrology & @JoshMeeks @NM_Urology > https://t.co/cJqV3Ay8oS ()
over 1 year ago
Clinical
|
Cxbladder
over1year
The real-life impact of @Cxbladder tests on diagnosis and surveillance of #BladderCancer. Presentation by @siadaneshmand @KeckMedUSC. #SUO22 written coverage by @rksayyid @UofT on UroToday > https://t.co/cdcwY5kGP0 @UroOnc @SUO_YUO @PacificEdgeLtd ()
over 1 year ago
Clinical
|
Cxbladder
over1year
“Remote” monitoring in urologic cancer: the case for home-based testing in #BladderCancer. Presentation by @SimaPorten @UCSFCancer. #SUO22 written coverage by @rksayyid @UofT > https://t.co/gkMk7Kayg1 @UroOnc @SUO_YUO @Cxbladder @PacificEdgeLtd ()
over 1 year ago
Cxbladder
over1year
From science to clinical utility: @Cxbladder Monitor - #BladderCancer surveillance for patients with urothelial carcinoma. Tamer Aboushwareb, MD, PhD @PacificEdgeLtd, Neal Shore, MD, FACS @AtlanticUrology & @JoshMeeks @NM_Urology > https://t.co/cJqV3Ay8oS ()
over 1 year ago
Clinical
|
Cxbladder
over1year
From science to clinical utility: @Cxbladder Detect - #BladderCancer detection for patients who present with hematuria. Tamer Aboushwareb, MD, PhD @PacificEdgeLtd, Neal Shore, MD, FACS @AtlanticUrology & @JoshMeeks @NM_Urology join to discuss on UroToday > https://t.co/ntpVmbLok6 ()
over 1 year ago
Clinical
|
Cxbladder
over1year
The real-life impact of @Cxbladder tests on diagnosis and surveillance of #BladderCancer. Presentation by @siadaneshmand @KeckMedUSC. #SUO22 written coverage by @rksayyid @UofT on UroToday > https://t.co/cdcwY5kGP0 @UroOnc @SUO_YUO @PacificEdgeLtd ()
over 1 year ago
Clinical
|
Cxbladder
over1year
.@PacificEdgeLtd H1 Cxbladder Cancer Tests Up 34% - subscribe to Biotech Daily https://t.co/4E9331THtC ()
over 1 year ago
Cxbladder
almost3years
Cxbladder is a non-invasive #bladdercancer surveillance alt. that can reduce the frequency of cystoscopy required in some patients. @SiaDaneshmand, @AnneSchuckmanMD, and @SimaPorten discuss their experiences incorporating it in a practice: https://t.co/rnA07O7Naf (via @GRUrology) (@Cxbladder)
almost 3 years ago
Clinical
|
Cxbladder
Share
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login